UroGen Pharma Ltd. (URGN)
28.89
-0.99
(-3.31%)
USD |
NASDAQ |
May 22, 16:00
28.87
-0.02
(-0.07%)
After-Hours: 20:00
UroGen Pharma Profit Margin (Quarterly) : -46.26% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -- |
| BioCryst Pharmaceuticals, Inc. | -461.5% |
| United Therapeutics Corp. | 35.18% |
| Puma Biotechnology, Inc. | -8.37% |
| TG Therapeutics, Inc. | 9.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -60.80% |
| Return on Invested Capital | -294.8% |
| Gross Profit Margin (Quarterly) | 91.88% |
| Operating Margin (Quarterly) | -39.76% |
| Return on Net Operating Assets | -270.4% |